Pages that link to "Q37119850"
Jump to navigation
Jump to search
The following pages link to Different response of human glioma tumor-initiating cells to epidermal growth factor receptor kinase inhibitors (Q37119850):
Displaying 50 items.
- In vitro and in vivo characterization of highly purified human mesothelioma derived cells (Q21261310) (← links)
- Molecular biomarkers of cancer stem/progenitor cells associated with progression, metastases, and treatment resistance of aggressive cancers (Q26822406) (← links)
- Targeting glioma stem cells: a novel framework for brain tumors (Q27026818) (← links)
- Retracted: EGFR Inhibition in Glioma Cells Modulates Rho Signaling to Inhibit Cell Motility and Invasion and Cooperates with Temozolomide to Reduce Cell Growth (Q28728770) (← links)
- Delineating the cytogenomic and epigenomic landscapes of glioma stem cell lines (Q31112229) (← links)
- CXCL12 modulation of CXCR4 and CXCR7 activity in human glioblastoma stem-like cells and regulation of the tumor microenvironment (Q33677057) (← links)
- Small molecules targeting histone demethylase genes (KDMs) inhibit growth of temozolomide-resistant glioblastoma cells (Q33798642) (← links)
- Potential therapeutic implications of cancer stem cells in glioblastoma (Q33965491) (← links)
- New promising drug targets in cancer- and metastasis-initiating cells (Q34003691) (← links)
- Targeting cancer stem cell plasticity through modulation of epidermal growth factor and insulin-like growth factor receptor signaling in head and neck squamous cell cancer (Q34109375) (← links)
- CXCR4 expression in feline mammary carcinoma cells: evidence of a proliferative role for the SDF-1/CXCR4 axis. (Q34195197) (← links)
- Frequent deregulations in the hedgehog signaling network and cross-talks with the epidermal growth factor receptor pathway involved in cancer progression and targeted therapies (Q34244929) (← links)
- Two mature products of MIR-491 coordinate to suppress key cancer hallmarks in glioblastoma (Q34381578) (← links)
- Novel therapies against aggressive and recurrent epithelial cancers by molecular targeting tumor- and metastasis-initiating cells and their progenies (Q34382586) (← links)
- New advances on critical implications of tumor- and metastasis-initiating cells in cancer progression, treatment resistance and disease recurrence (Q34382914) (← links)
- Identification of a novel set of genes reflecting different in vivo invasive patterns of human GBM cells. (Q34383355) (← links)
- Multi-scale agent-based brain cancer modeling and prediction of TKI treatment response: incorporating EGFR signaling pathway and angiogenesis (Q34398148) (← links)
- Metformin repositioning as antitumoral agent: selective antiproliferative effects in human glioblastoma stem cells, via inhibition of CLIC1-mediated ion current (Q34957274) (← links)
- Differential distribution of erbB receptors in human glioblastoma multiforme: expression of erbB3 in CD133-positive putative cancer stem cells (Q35214798) (← links)
- In vitro and in vivo antiproliferative activity of metformin on stem-like cells isolated from spontaneous canine mammary carcinomas: translational implications for human tumors (Q35425337) (← links)
- 2-Hydroxyoleate, a nontoxic membrane binding anticancer drug, induces glioma cell differentiation and autophagy. (Q36001206) (← links)
- Activation of multiple ERBB family receptors mediates glioblastoma cancer stem-like cell resistance to EGFR-targeted inhibition. (Q36062158) (← links)
- Preclinical studies identify novel targeted pharmacological strategies for treatment of human malignant pleural mesothelioma (Q36159154) (← links)
- Complex Oncogenic Signaling Networks Regulate Brain Tumor‐Initiating Cells and Their Progenies: Pivotal Roles of Wild‐Type EGFR, EGFRvIII Mutant and Hedgehog Cascades and Novel Multitargeted Therapies (Q36280796) (← links)
- Suppression of RAF/MEK or PI3K synergizes cytotoxicity of receptor tyrosine kinase inhibitors in glioma tumor-initiating cells (Q36560547) (← links)
- Metformin selectively affects human glioblastoma tumor-initiating cell viability: A role for metformin-induced inhibition of Akt. (Q36604614) (← links)
- Sorafenib selectively depletes human glioblastoma tumor-initiating cells from primary cultures. (Q36654402) (← links)
- Essential gene pathways for glioblastoma stem cells: clinical implications for prevention of tumor recurrence. (Q37132697) (← links)
- Delivery of molecularly targeted therapy to malignant glioma, a disease of the whole brain (Q37308322) (← links)
- Inhibition of the Autophagy Pathway Synergistically Potentiates the Cytotoxic Activity of Givinostat (ITF2357) on Human Glioblastoma Cancer Stem Cells. (Q37368670) (← links)
- Abrogation of mitogen-activated protein kinase and Akt signaling by vandetanib synergistically potentiates histone deacetylase inhibitor-induced apoptosis in human glioma cells (Q37397228) (← links)
- Cellular prion protein controls stem cell-like properties of human glioblastoma tumor-initiating cells (Q37437614) (← links)
- Targeting CD133 antigen in cancer (Q37521082) (← links)
- Down-modulation of SEL1L, an unfolded protein response and endoplasmic reticulum-associated degradation protein, sensitizes glioma stem cells to the cytotoxic effect of valproic acid. (Q37536543) (← links)
- Brain cancer stem cells. (Q37604204) (← links)
- Altered gene products involved in the malignant reprogramming of cancer stem/progenitor cells and multitargeted therapies (Q37610799) (← links)
- Signaling in malignant astrocytomas: role of neural stem cells and its therapeutic implications. (Q37637707) (← links)
- Targeted therapy in the treatment of malignant gliomas (Q37771247) (← links)
- Cancer stem cells in glioblastoma—molecular signaling and therapeutic targeting (Q37825821) (← links)
- Cancer stem cells: the development of new cancer therapeutics. (Q37861207) (← links)
- KRAS-Mutation Positive, Metastatic Tonsil Carcinoma With Cancer Stem-Like Cell Features and Long-Term Response to Gefitinib: A Case Report and Review of the Literature (Q37873685) (← links)
- MicroRNAs as regulators of neural stem cell-related pathways in glioblastoma multiforme (Q37897499) (← links)
- Characteristic features of stem cells in glioblastomas: from cellular biology to genetics (Q37981219) (← links)
- Neuronal stem cells in the central nervous system and in human diseases (Q38005043) (← links)
- Reversion of the ErbB malignant phenotype and the DNA damage response. (Q38047648) (← links)
- The future of glioma treatment: stem cells, nanotechnology and personalized medicine (Q38048888) (← links)
- EGFR signaling and autophagy dependence for growth, survival, and therapy resistance (Q38171032) (← links)
- New molecules and old drugs as emerging approaches to selectively target human glioblastoma cancer stem cells (Q38187997) (← links)
- Recent advances in targeted therapy for glioblastoma (Q38539386) (← links)
- The histone demethylase KDM5A is a key factor for the resistance to temozolomide in glioblastoma. (Q38819651) (← links)